What type of study is this?

This is a Quantitative Study study (also classified as: Cohort Study, Human Clinical Trial).

October 9, 2025Open Access

Bacillus mojavensis postbiotics: transcriptomic and anticancer effects in colon cancer cells

View Full Paper

Ask AI

Bookmark

Authors

MTMaría Alejandra Trujillo-LópezUniversidad Popular Autónoma del Estado de Puebla CMCristina Muñoz-OlivosUniversidad Popular Autónoma del Estado de Puebla MGMiguel Ángel Garduño-VargasUniversidad Popular Autónoma del Estado de Puebla

Discussion

Member takes

Implication

Analysis reveals postbiotics from Bacillus mojavensis have significant antiproliferative effects in colon cancer, indicating potential therapeutic applications.

Key Points

Treatment with Bacillus mojavensis postbiotics reduced the viability of over 75% of colon cancer cells within 24 hours.
The postbiotic significantly inhibited cell migration and decreased LPS-induced proliferation without harming healthy cells.
Transcriptomic profiling showed extensive modulation of oncogenes and tumor suppressor pathways associated with cancer.
Bacillus mojavensis postbiotics may offer a selective anticancer approach by targeting malignant cells while sparing normal ones.

Cite This Study

Trujillo-López et al. (2025) studied this question.

synapsesocial.com/papers/68e77f09d1c187e1c108fa7d https://doi.org/10.21203/rs.3.rs-7574147/v1

View Full Paper

Ask AI

Bookmark

Implication

Analysis reveals postbiotics from Bacillus mojavensis have significant antiproliferative effects in colon cancer, indicating potential therapeutic applications.

Bacillus mojavensis postbiotics: transcriptomic and anticancer effects in colon cancer cells

Discussion

Member takes

Implication

Key Points

Cite This Study

Bacillus mojavensis postbiotics: transcriptomic and anticancer effects in colon cancer cells

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider